📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

AbbVie Inc

Common Name

AbbVie

Country

United States

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

55,000

Ticker

ABBV

Exchange

NEW YORK STOCK EXCHANGE, INC.

Website

www.abbvie.com

Description

AbbVie Inc. is a leading global biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of innovative pharmaceuticals. Established as a spin-off from Abbott ... Show more

Income Statement Balance Sheet Group Entities

AbbVie's Financial Statements Preview

Below are the financial statements of AbbVie, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in millions of USD	2024 as of 2024-12-31	2023 as of 2023-12-31
Assets	—	—
Current assets	—	—
Cash and equivalents	5,524^a	12,814^a
Short-term investments	31^a	2^a
Accounts receivable, net	10,919^a	11,155^a
Inventories	4,181^a	4,099^a
Prepaid expenses and other	4,927^a	4,932^a
Total current assets	25,582^a	33,002^a
Investments	279^a	304^a
Property and equipment, net	5,134^a	4,989^a
Intangible assets, net	60,068^a	55,610^a
Goodwill	34,956^a	32,293^a
Other assets	9,142^a	8,513^a
Total assets	135,161^a	134,711^a
Liabilities and equity	—	—
Current liabilities	—	—
Current portion of long-term debt and finance lease obligations	6,804^a	7,191^a
Accounts payable and accrued liabilities	31,945^a	30,650^a
Total current liabilities	38,749^a	37,841^a
Long-term debt and finance lease obligations	60,340^a	52,194^a
Deferred income taxes	2,579^a	1,952^a
Other long-term liabilities	30,129^a	32,327^a
Stockholders' equity	—	—
Common stock	18^a	18^a
Common stock held in treasury, at cost	-8,201^a	-6,533^a
Additional paid-in capital	21,333^a	20,180^a
Accumulated deficit	-7,900^a	-1,000^a
Accumulated other comprehensive loss	-1,925^a	-2,305^a
Total stockholders' equity	3,325^a	10,360^a
Noncontrolling interest	39^a	37^a
Total equity	3,364^a	10,397^a
Total liabilities and equity	135,161^a	134,711^a

Verified Sources Behind AbbVie’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore AbbVie’s data sources below and access millions more through our Disclosure Search.

a. AbbVie's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

AbbVie Inc

AbbVie's Financial Statements Preview

AbbVie's Financial Statements Preview

Verified Sources Behind AbbVie’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Merck & Co Inc

Organon & Co

Biogen Inc

Gilead Sciences Inc

Danaher Corp

Tenet Healthcare Corp